JP Morgan Chase’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.5M | Buy |
70,874
+39,585
| +127% | +$6.08M | ﹤0.01% | 2553 |
|
|
2025
Q4 | $4.29M | Sell |
31,289
-23,921
| -43% | -$3.09M | ﹤0.01% | 3460 |
|
|
2025
Q3 | $6.71M | Buy |
55,210
+3,698
| +7% | +$399K | ﹤0.01% | 3104 |
|
|
2025
Q2 | $5.51M | Sell |
51,512
-16,318
| -24% | -$1.63M | ﹤0.01% | 3066 |
|
|
2025
Q1 | $6.29M | Buy |
67,830
+4,685
| +7% | +$454K | ﹤0.01% | 2958 |
|
|
2024
Q4 | $6.79M | Buy |
63,145
+20,072
| +47% | +$2.44M | ﹤0.01% | 3066 |
|
|
2024
Q3 | $5.42M | Buy |
43,073
+2,419
| +6% | +$304K | ﹤0.01% | 3160 |
|
|
2024
Q2 | $4.41M | Sell |
40,654
-746
| -2% | -$72.7K | ﹤0.01% | 3127 |
|
|
2024
Q1 | $3.91M | Sell |
41,400
-84,796
| -67% | -$8.03M | ﹤0.01% | 3307 |
|
|
2023
Q4 | $11.7M | Buy |
126,196
+3,934
| +3% | +$301K | ﹤0.01% | 2317 |
|
|
2023
Q3 | $7.82M | Sell |
122,262
-6,862
| -5% | -$440K | ﹤0.01% | 2478 |
|
|
2023
Q2 | $7.98M | Buy |
129,124
+90,598
| +235% | +$5.37M | ﹤0.01% | 2480 |
|
|
2023
Q1 | $2.24M | Buy |
38,526
+46
| +0.1% | +$2.64K | ﹤0.01% | 3462 |
|
|
2022
Q4 | $2.29M | Sell |
38,480
-98,601
| -72% | -$5.98M | ﹤0.01% | 3458 |
|
|
2022
Q3 | $8.68M | Sell |
137,081
-24,013
| -15% | -$1.67M | ﹤0.01% | 2270 |
|
|
2022
Q2 | $11.3M | Sell |
161,094
-470
| -0.3% | -$32.9K | ﹤0.01% | 2050 |
|
|
2022
Q1 | $11.3M | Sell |
161,564
-21,072
| -12% | -$1.42M | ﹤0.01% | 2247 |
|
|
2021
Q4 | $12.4M | Buy |
182,636
+54,685
| +43% | +$3.78M | ﹤0.01% | 2264 |
|
|
2021
Q3 | $8.95M | Buy |
127,951
+21,337
| +20% | +$1.55M | ﹤0.01% | 2479 |
|
|
2021
Q2 | $7.45M | Sell |
106,614
-64,279
| -38% | -$4.67M | ﹤0.01% | 2691 |
|
|
2021
Q1 | $13.3M | Sell |
170,893
-6,132
| -3% | -$434K | ﹤0.01% | 2102 |
|
|
2020
Q4 | $11.8M | Buy |
177,025
+81,002
| +84% | +$5.34M | ﹤0.01% | 2081 |
|
|
2020
Q3 | $5.93M | Sell |
96,023
-1,177
| -1% | -$73.6K | ﹤0.01% | 2417 |
|
|
2020
Q2 | $6.17M | Sell |
97,200
-27,764
| -22% | -$1.86M | ﹤0.01% | 2299 |
|
|
2020
Q1 | $8.96M | Buy |
124,964
+114,317
| +1,074% | +$9.04M | ﹤0.01% | 1841 |
|
|
2019
Q4 | $920K | Buy |
10,647
+122
| +1% | +$10.2K | ﹤0.01% | 3921 |
|
|
2019
Q3 | $861K | Buy |
10,525
+7,168
| +214% | +$593K | ﹤0.01% | 3913 |
|
|
2019
Q2 | $270K | Sell |
3,357
-995
| -23% | -$76.8K | ﹤0.01% | 4541 |
|
|
2019
Q1 | $331K | Sell |
4,352
-1,431
| -25% | -$114K | ﹤0.01% | 4404 |
|
|
2018
Q4 | $454K | Buy |
5,783
+2,973
| +106% | +$233K | ﹤0.01% | 4181 |
|
|
2018
Q3 | $212K | Buy |
2,810
+522
| +23% | +$38.4K | ﹤0.01% | 4671 |
|
|
2018
Q2 | $161K | Buy |
2,288
+28
| +1% | +$1.83K | ﹤0.01% | 4659 |
|
|
2018
Q1 | $135K | Sell |
2,260
-6,792
| -75% | -$416K | ﹤0.01% | 4501 |
|
|
2017
Q4 | $552K | Buy |
9,052
+4,559
| +101% | +$291K | ﹤0.01% | 4022 |
|
|
2017
Q3 | $283K | Sell |
4,493
-4,090
| -48% | -$264K | ﹤0.01% | 4008 |
|
|
2017
Q2 | $602K | Buy |
8,583
+1,653
| +24% | +$118K | ﹤0.01% | 3645 |
|
|
2017
Q1 | $494K | Sell |
6,930
-10,214
| -60% | -$756K | ﹤0.01% | 3711 |
|
|
2016
Q4 | $1.3M | Buy |
17,144
+14,234
| +489% | +$986K | ﹤0.01% | 3314 |
|
|
2016
Q3 | $192K | Buy |
+2,910
| New | +$189K | ﹤0.01% | 3706 |
|
|
2016
Q1 | – | Sell |
-657,293
| Closed | -$40.6M | – | 4849 |
|
|
2015
Q4 | $40.6M | Sell |
657,293
-14,810
| -2% | -$960K | 0.01% | 913 |
|
|
2015
Q3 | $40.9M | Sell |
672,103
-1,916
| -0.3% | -$120K | 0.01% | 878 |
|
|
2015
Q2 | $43.8M | Sell |
674,019
-11,891
| -2% | -$755K | 0.01% | 953 |
|
|
2015
Q1 | $43.7M | Sell |
685,910
-4,840
| -0.7% | -$307K | 0.01% | 959 |
|
|
2014
Q4 | $43.4M | Sell |
690,750
-4,675
| -0.7% | -$281K | 0.01% | 1005 |
|
|
2014
Q3 | $38.6M | Buy |
695,425
+8,582
| +1% | +$485K | 0.01% | 1042 |
|
|
2014
Q2 | $38.7M | Buy |
686,843
+4,287
| +0.6% | +$233K | 0.01% | 980 |
|
|
2014
Q1 | $38.1M | Buy |
682,556
+28,260
| +4% | +$1.48M | 0.01% | 956 |
|
|
2013
Q4 | $35.3M | Buy |
654,296
+13,757
| +2% | +$703K | 0.01% | 983 |
|
|
2013
Q3 | $30.3M | Buy |
640,539
+35,115
| +6% | +$1.68M | 0.01% | 1072 |
|
|
2013
Q2 | $28.9M | Buy |
+605,424
| New | +$28.3M | 0.01% | 1028 |
|
Other funds holding NHC
MSIIA
VPM
VCM
MHS
JP Morgan Chase's NHC Position: Q1 2026 in Review
JP Morgan Chase increased its National Healthcare (NHC) stake by 127% in Q1 2026, buying an estimated $6.08M and bringing the position to 70,874 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2553.
JP Morgan Chase first reported a position in NHC in Q2 2013 and has held it in 50 quarters since. The position peaked at $43.8M in Q2 2015. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.
- JP Morgan Chase held 70,874 shares of National Healthcare worth $11.5M as of Q1 2026.
- JP Morgan Chase bought 39,585 National Healthcare shares in Q1 2026, an estimated $6.08M.
- National Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2553 holding.
- JP Morgan Chase first reported a position in National Healthcare in Q2 2013 and has held it in 50 quarters since.
- JP Morgan Chase's National Healthcare position peaked at $43.8M in Q2 2015.
- 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.